New investigation reveals potentially fatal side effects of popular weight-loss drugs

Weight-loss drugs like Ozempic, while revolutionary, are under scrutiny as the UK’s MHRA investigates serious pancreas trouble reported by GLP-1 users, including fatalities. Over 400 reports of pancreatitis, with at least 10 deaths, have prompted a study with Genomics England to explore genetic predispositions to this side effect. Novo Nordisk emphasizes using the drugs under medical supervision. Read more below!